The arrival of Semaglutide at a higher strength represents a notable development in managing type 2 diabetes. Before, reduced doses were typically administered, but this latest formulation provides the potential for improved glucose control in certain people. Doctors are evaluating its impact and security profile, specifically in individuals who… Read More